A cyberattack on U.S. medical device maker Boston Scientific is causing an ongoing “global disruption” to its operations, according to a federal regulatory filing on Wednesday, the latest healthtech giant to face a cyberattack in recent weeks.
The Massachusetts-based company, which makes medically implanted devices like pacemakers and defibrillators, confirmed in a filing with the U.S. Securities and Exchange Commission that on Tuesday it began experiencing “disruptions and limitations of access” to its IT systems and business applications critical for its operations.
